 Oramed Pharmaceuticals Inc NASDAQ: ORMP has entered into definitive agreements to form a joint venture focused on developing oral COVID-19 vaccines. The new company, Oravax Medical Inc, will use Orameds proprietary POD oral delivery technology and Premas Biotech Pvt. 